| 2026-05-22 |
详情>>
内部人交易：
Jankovic Walter共交易2笔
|
| 2026-05-13 |
详情>>
股本变动：
变动后总股本10849.64万股
|
| 2026-05-13 |
详情>>
业绩披露：
2026年一季报每股收益0.07美元,归母净利润730.90万美元,同比去年增长23.05%
|
| 2026-05-11 |
财报披露：
美东时间 2026-05-11 盘后发布财报
|
| 2026-04-24 |
股东大会：
将于2026-06-04召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the earlier of the 2027 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To hold an advisory vote on the frequency of future stockholder advisory votes on named executive officer compensation;
4.To approve an amendment to the Harmonic Inc. 2025 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 7,000,000 shares;
5.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2026-02-24 |
详情>>
业绩披露：
2025年年报每股收益-0.38美元,归母净利润-4331万美元,同比去年增长-210.44%
|
| 2026-02-24 |
详情>>
业绩披露：
2023年年报每股收益0.75美元,归母净利润8399.40万美元,同比去年增长198.04%
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.10美元,归母净利润1150.50万美元,同比去年增长948.77%
|
| 2025-08-01 |
详情>>
业绩披露：
2025年中报每股收益0.08美元,归母净利润881.10万美元,同比去年增长142.73%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益0.05美元,归母净利润594.00万美元,同比去年增长173.43%
|
| 2025-04-30 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.To elect eight (8) directors to serve until the earlier of the 2026 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 500,000 shares;
4.To approve the Harmonic Inc. 2025 Equity Incentive Plan;
5.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2025-02-14 |
详情>>
业绩披露：
2022年年报每股收益0.27美元,归母净利润2818.20万美元,同比去年增长112.63%
|
| 2025-02-14 |
详情>>
业绩披露：
2024年年报每股收益0.34美元,归母净利润3921.70万美元,同比去年增长-53.31%
|
| 2024-11-01 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.01美元,归母净利润109.70万美元,同比去年增长616.99%
|
| 2024-08-02 |
详情>>
业绩披露：
2024年中报每股收益-0.18美元,归母净利润-2062.1万美元,同比去年增长-410.18%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.07美元,归母净利润-808.9万美元,同比去年增长-258.83%
|
| 2024-04-29 |
股东大会：
将于2024-06-11召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the earlier of the 2025 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 400,000 shares;
4.To approve an amendment to the 1995 Stock Plan to (i) increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares and (ii) extend the term of the 1995 Stock Plan to March 1, 2030;
5.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2023-04-28 |
股东大会：
将于2023-06-23召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2024 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 650,000 shares;
4.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023;
5.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2022-04-29 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect nine (9) directors to serve until the earlier of the 2023 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,000,000 shares;
4.To approve an amendment to the 1995 Stock Plan to increase the number of shares of common stock reserved for issuance thereunder by 7,000,000 shares;
5.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-28 |
股东大会：
将于2021-06-08召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2022 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,000,000 shares;
4.To approve an amendment to the 2002 Director Stock Plan to increase the number of shares of common stock reserved for issuance thereunder by 450,000 shares;
5.To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2020-04-30 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2021 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,000,000 shares;
4.To approve an amendment to the 1995 Stock Plan to increase the number of shares of common stock reserved for issuance thereunder by 4,000,000 shares;
5.To ratify the appointment of Armanino LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2020-03-16 |
复牌提示：
2020-03-16 09:46:21 停牌，复牌日期 2020-03-16 09:51:21
|
| 2019-04-26 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2020 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the Company’s 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,000,000 shares;
4.To approve an amendment to the Company’s 1995 Stock Plan to (i) increase the number of shares of common stock reserved for issuance thereunder by 3,500,000 shares; (ii) reduce the number of shares of common stock debited against the 1995 Stock Plan with respect to new grants of restricted stock units; (iii) increase the annual award limits; and (iv) eliminate certain provisions relating to tax law changes applicable to Section 162(m) of the Internal Revenue Code of 1986, as amended;
5.To approve an amendment to the Company’s 2002 Director Stock Plan to (i) reduce the number of shares of common stock debited against the 2002 Director Stock Plan with respect to new grants of restricted stock units and (ii) institute an annual limit of $600,000 with respect to cash and equity awards made to any non-employee director;
6.To ratify the appointment of Armanino LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019;
7.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2018-04-27 |
股东大会：
将于2018-06-08召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2019 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2. To hold an advisory vote to approve named executive officer compensation;
3.To approve an amendment to the Company’s 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,300,000 shares;
4.To approve an amendment to the Company’s 2002 Director Stock Plan to increase the number of shares of common stock reserved for issuance thereunder by 400,000 shares;
5.To ratify the appointment of Armanino LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2017-05-01 |
股东大会：
将于2017-06-13召开股东大会
会议内容 ▼▲
- 1. To elect seven (7) directors to serve until the earlier of the 2018 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2. To hold an advisory vote to approve named executive officer compensation;
3. To hold an advisory vote on the frequency of future advisory votes on named executive officer compensation;
4. To approve an amendment to the Company’s 2002 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder by 1,500,000 shares;
5. To approve an amendment to the Company’s 1995 Stock Plan to (i) increase the number of shares of common stock reserved for issuance thereunder by 7,000,000 shares and (ii) extend the term of the 1995 Stock Plan to March 1, 2025;
6. To approve an amendment to the Company’s 2002 Director Stock Plan to (i) increase the number of shares of common stock reserved for issuance thereunder by 400,000 shares and (ii) extend the term of the 2002 Director Stock Plan to March 1, 2025;
7. To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017;
8. To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-09召开股东大会
会议内容 ▼▲
- 1.To elect seven (7) directors to serve until the earlier of the 2017 annual meeting of stockholders or until their successors are elected and qualified or until their earlier resignation or removal;
2.To hold an advisory vote on executive compensation;
3.To approve an amendment to the Company’s 2002 Employee Stock Purchase Plan to increase the number of shares of Common stock reserved for issuance thereunder by 1,500,000 shares;
4.To approve an amendment to the Company’s 1995 Stock Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares;
5.To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016;
6.To transact such other matters as may properly come before the Annual Meeting or any adjournment, postponement or other delay thereof.
|